Investigation on the Efficacy and Safety of Carteolol/Latanoprost Combination Ophthalmic Solution to Timolol/Latanoprost Combination Ophthalmic Solution in Patients with Glaucoma
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2018
At a glance
- Drugs Carteolol/latanoprost (Primary) ; Latanoprost/timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2018 Status changed from suspended to discontinued.
- 30 Mar 2018 Status changed from recruiting to suspended.
- 08 Dec 2017 New trial record